Skip NavigationSkip to Content

Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014)

  1. Author:
    Galindo-Fraga, Arturo
    Del Carmen Guerra-de-Blas, Paola
    Ortiz-Hernández, Ana A
    Rubenstein,Kevin
    Ortega-Villa, Ana M
    Ramírez-Venegas, Alejandra
    Valdez-Vázquez, Rafael
    Moreno-Espinosa, Sarbelio
    Llamosas-Gallardo, Beatriz
    Pérez-Patrigeon, Santiago
    Noyola, Daniel E
    Magaña-Aquino, Martín
    Vilardell-Dávila, Ana
    Guerrero, M Lourdes
    Powers, John H
    Beigel, John
    Ruiz-Palacios, Guillermo M
  2. Author Address

    1Subdirección de Epidemiología Hospitalaria, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 2The Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico. 3División de Desarrollo y Enlace Interinstitucional, Instituto Nacional de Pediatría, Mexico City, Mexico. 4Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. 5National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. 6Departamento de Investigación en Tabaquismo y EPOC, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico. 7Departamento de Infectología, Hospital General Dr. Manuel Gea González, Mexico City, Mexico. 8Departamento de Infectología, Hospital Infantil de México Federico Gómez, Mexico City, Mexico. 9Division of Infectious Diseases, Queen's University, Kingston, Ontario, Canada. 10Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 11Departamento de Microbiología y Centro de Investigación en Ciencias de la Salud y Biomedicina, Facultad de Medicina, Universidad Autónoma de San Luís Potosí, San Luis Potosí, Mexico. 12Hospital Regional Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico. 13Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
    1. Year: 2024
    2. Date: Sep
    3. Epub Date: 2024 06 21
  1. Journal: IJID Regions
    1. 12
    2. Pages: 100394
  2. Type of Article: Article
  3. Article Number: 100394
  1. Abstract:

    Influenza-like illness (ILI) caused by respiratory viruses results in various respiratory clinical manifestations. The ILI002 prospective observational cohort study aimed to describe viral agents, seasonality, and outcomes of patients with ILI during four seasons in the influenza H1N1-pandemic and post-pandemic years (2010-2014). Patients from six Mexican hospitals were enrolled from April 2010 to March 2014. Clinical data and nasopharyngeal swabs were obtained and tested for viral respiratory pathogens by real-time reverse-transcription polymerase chain reaction. Of the 5662 enrolled participants, 64.9% were adults and 35.1% were children. Among the 5629 participants with single-pathogen detection, rhinovirus (20.2%), influenza virus (11.2%), respiratory syncytial virus (RSV) (7.2%), and coronavirus (6.8%) were the most frequent pathogens. Co-infection occurred in 14.5% of cases; 49.3% of participants required hospitalization, particularly in RSV cases (42.9% adults, 89.6% children). The mortality rate was 2.8% higher among older adult participants and those with comorbidities. Influenza H1N1 had the highest mortality rate, yet almost half of the deceased had no pathogen. Rhinovirus persisted year-round, while influenza, coronavirus, and RSV peaked during cooler months. Analyses showed that some viruses causing ILI may lead to severe disease and hospitalization irrespective of comorbidities. These findings may help in decision-making about public health policies on prevention measures, vaccination, treatment, and administration of health care. © 2024 The Author(s).

    See More

External Sources

  1. DOI: 10.1016/j.ijregi.2024.100394
  2. PMID: 39045384
  3. PMCID: PMC11265585
  4. PII : S2772-7076(24)00065-1

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel